Zomedica Corporation (ZOM): Rasio Total Utang marang Ekuitas

Market dynamics on GURU.Markets reflect the total debt-to-equity ratio of Zomedica Corp. (ZOM), which stands at 0.00. The business maintains stability through its patented TRUFORMA platforms and investments in R&D. Zomedica Corp. (ZOM) generates revenue from the sale of rapid testing systems and ancillary components for veterinary medicine. High margins are achieved through exclusive cartridges, which make it extremely difficult for clinics to switch to alternative equipment.
Rincian metrik lan analitis perusahaan Zomedica (ZOM)

The total debt-to-equity ratio measures the proportion of borrowed funds relative to equity, determining the degree of financial leverage and the risk of dependence on creditors. By analyzing the historical changes in the total debt-to-equity ratio, an investor can assess how effectively Zomedica Corp. (ZOM) is financing the deployment of the Inertia platform to generate long-term revenue streams from the sale of disposable cartridges.